TickerFactsScreenerDevelopers

Quince Therapeutics, Inc. (QNCX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$11.70M2019: -$33.28M2020: -$50.82M2021: -$62.93M2022: -$44.04M2023: -$18.29M2024: -$31.90M2025: -$41.42M-$41.42M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$41.42M-29.8%
2024-$31.90M-74.4%
2023-$18.29M+58.5%
2022-$44.04M+30.0%
2021-$62.93M-23.8%
2020-$50.82M-52.7%
2019-$33.28M-184.5%
2018-$11.70M—